Using active stimulation, we are focusing on major diseases such as breast and prostate cancer, HPV-associated cancers, influenza, HPV and HIV. In addition, by altering the dosing regimen, pre-clinical investigations are establishing the potential of using our antigen-specific peptide technology to inhibit the aberrant autoimmune response at the root of diseases such as diabetes and multiple scler